U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 48

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr16:11001864
GRCh38:
Chr16:10908007
CIITAR791G, R839G, R790G, R840G, R816GRheumatoid arthritis, MHC class II deficiency, MHC class II deficiency
Uncertain significance
(Sep 17, 2021)
criteria provided, multiple submitters, no conflicts
2.
GRCh37:
Chr16:10996517
GRCh38:
Chr16:10902660
CIITAP162S, P163S, P211S, P188S, P212SRheumatoid arthritis, MHC class II deficiency, MHC class II deficiency
Uncertain significance
(Jul 19, 2022)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr16:11001724
GRCh38:
Chr16:10907867
CIITAY743F, Y744F, Y769F, Y792F, Y793FMHC class II deficiency, Rheumatoid arthritisUncertain significance
(Mar 30, 2021)
criteria provided, single submitter
4.
GRCh37:
Chr16:10998628
GRCh38:
Chr16:10904771
CIITAP273L, P274L, P299L, P322L, P323LMHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
Uncertain significance
(Mar 14, 2022)
criteria provided, multiple submitters, no conflicts
5.
GRCh37:
Chr16:10989260
GRCh38:
Chr16:10895403
CIITAMHC class II deficiency, Rheumatoid arthritisUncertain significance
(Sep 28, 2021)
criteria provided, single submitter
6.
GRCh37:
Chr16:11004059
GRCh38:
Chr16:10910202
CIITAS360L, S895L, S896L, S921L, S944L, S945LMHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
Uncertain significance
(Jan 13, 2022)
criteria provided, multiple submitters, no conflicts
7.
GRCh37:
Chr16:11001913
GRCh38:
Chr16:10908056
CIITAA806V, A807V, A832V, A855V, A856VMHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
Uncertain significance
(Feb 23, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr4:38799129
GRCh38:
Chr4:38797508
TLR1C442RRheumatoid arthritisPathogenic
(Nov 2, 2020)
no assertion criteria provided
9.
GRCh37:
Chr4:38798417
GRCh38:
Chr4:38796796
TLR1I679TRheumatoid arthritisPathogenic
(Nov 2, 2020)
no assertion criteria provided
10.
GRCh37:
Chr2:233408368
GRCh38:
Chr2:232543658
CHRNGR332Wnot specified, Autosomal recessive multiple pterygium syndromeConflicting interpretations of pathogenicity
(Jun 15, 2023)
criteria provided, conflicting interpretations
11.
GRCh37:
Chr1:17660499
GRCh38:
Chr1:17334004
PADI4G112ARheumatoid arthritis, Abnormal pulmonary interstitial morphologyassociation
(Feb 1, 2020)
no assertion criteria provided
12.
GRCh37:
Chr1:17662662
GRCh38:
Chr1:17336167
PADI4Rheumatoid arthritis, Abnormal pulmonary interstitial morphologyassociation
(Feb 1, 2020)
no assertion criteria provided
13.
GRCh37:
Chr1:17657616
GRCh38:
Chr1:17331121
PADI4V82ARheumatoid arthritis, Abnormal pulmonary interstitial morphologyassociation
(Feb 1, 2020)
no assertion criteria provided
14.
GRCh37:
Chr1:17657534
GRCh38:
Chr1:17331039
PADI4G55SRheumatoid arthritis, Abnormal pulmonary interstitial morphologyassociation
(Feb 1, 2020)
no assertion criteria provided
15.
GRCh37:
Chr1:17444769
GRCh38:
Chr1:17118274
PADI2Rheumatoid arthritis, Abnormal pulmonary interstitial morphologyassociation
(Feb 1, 2020)
no assertion criteria provided
16.
GRCh37:
Chr1:17413121
GRCh38:
Chr1:17086626
PADI2Rheumatoid arthritis, Abnormal pulmonary interstitial morphologyassociation
(Feb 1, 2020)
no assertion criteria provided
17.
GRCh37:
Chr1:17405949
GRCh38:
Chr1:17079454
PADI2Rheumatoid arthritis, Abnormal pulmonary interstitial morphologyassociation
(Feb 1, 2020)
no assertion criteria provided
18.
GRCh37:
Chr1:17395281
GRCh38:
Chr1:17068786
PADI2Rheumatoid arthritis, Abnormal pulmonary interstitial morphologyassociation
(Feb 1, 2020)
no assertion criteria provided
19.
GRCh37:
Chr16:11001288
GRCh38:
Chr16:10907431
CIITAR624C, R598C, R647C, R648C, R599CMHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
Uncertain significance
(Jul 24, 2022)
criteria provided, multiple submitters, no conflicts
20.
GRCh37:
Chr16:11016071
GRCh38:
Chr16:10922214
CIITAR1017H, R1018H, R1043H, R1066H, R1067H, R482HInborn genetic diseases, MHC class II deficiency, Rheumatoid arthritis,
MHC class II deficiency
Conflicting interpretations of pathogenicity
(Aug 15, 2022)
criteria provided, conflicting interpretations
21.
GRCh37:
Chr16:11001462
GRCh38:
Chr16:10907605
CIITAE656K, E657K, E705K, E682K, E706KMHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
Uncertain significance
(Mar 14, 2022)
criteria provided, multiple submitters, no conflicts
22.
GRCh37:
Chr16:11001462
GRCh38:
Chr16:10907605
CIITAE657Q, E682Q, E706Q, E656Q, E705QRheumatoid arthritis, MHC class II deficiency, MHC class II deficiency
Uncertain significance
(Sep 28, 2021)
criteria provided, multiple submitters, no conflicts
23.
GRCh37:
Chr16:10992600
GRCh38:
Chr16:10898743
CIITAMHC class II deficiency, MHC class II deficiency, Rheumatoid arthritis
Benign
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
24.
GRCh37:
Chr16:11004037
GRCh38:
Chr16:10910180
CIITAMHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
Conflicting interpretations of pathogenicity
(Mar 14, 2022)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr16:11347858
GRCh38:
Chr16:11254001
SOCS1, SOCS1, SOCS1Rheumatoid arthritisAffects
(Nov 30, 2019)
no assertion criteria provided
26.
GRCh37:
Chr16:10997746
GRCh38:
Chr16:10903889
CIITAM311V, M262V, M312V, M263V, M288VMHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
Conflicting interpretations of pathogenicity
(Oct 17, 2022)
criteria provided, conflicting interpretations
27.
GRCh37:
Chr16:10997744
GRCh38:
Chr16:10903887
CIITAN310I, N311I, N261I, N262I, N287IMHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
Uncertain significance
(Mar 30, 2021)
criteria provided, single submitter
28.
GRCh37:
Chr16:11017111
GRCh38:
Chr16:10923254
CIITAS1115N, S1116N, S531N, S1066N, S1067N, S1092NRheumatoid arthritis, MHC class II deficiency, MHC class II deficiency,
Rheumatoid arthritis, Colitis, Thrombocytopenia,
Inflammation of the large intestine, Hematochezia
Uncertain significance
(Oct 24, 2022)
criteria provided, multiple submitters, no conflicts
29.
GRCh37:
Chr1:17484166
GRCh38:
Chr1:17157671
PADI4Rheumatoid arthritisassociationno assertion criteria provided
30.
GRCh37:
Chr1:17662639
GRCh38:
Chr1:17336144
PADI4Rheumatoid arthritisassociationno assertion criteria provided
31.
GRCh37:
Chr16:11000905
GRCh38:
Chr16:10907048
CIITAP519L, P520L, P470L, P471L, P496LMHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
Uncertain significance
(Sep 27, 2022)
criteria provided, multiple submitters, no conflicts
32.
GRCh37:
Chr16:10992538
GRCh38:
Chr16:10898681
CIITAQ103K, Q79KMHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
Uncertain significance
(Dec 15, 2021)
criteria provided, multiple submitters, no conflicts
33.
GRCh37:
Chr16:11016091
GRCh38:
Chr16:10922234
CIITAS1073T, S1074T, S489T, S1025T, S1050T, S1024TMHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
Uncertain significance
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
34.
GRCh37:
Chr16:10992836
GRCh38:
Chr16:10898979
CIITAV138A, V139A, V115AMHC class II deficiency, Rheumatoid arthritis, MHC class II deficiency
Uncertain significance
(Aug 23, 2022)
criteria provided, multiple submitters, no conflicts
35.
GRCh37:
Chr13:37622040
GRCh38:
Chr13:37047903
SUPT20HK25*Rheumatoid arthritisrisk factor
(Jun 16, 2017)
no assertion criteria provided
36.
GRCh37:
Chr16:10989612
GRCh38:
Chr16:10895755
CIITAA96T, A72TInborn genetic diseases, MHC class II deficiency, Rheumatoid arthritis,
MHC class II deficiency
Uncertain significance
(Aug 19, 2022)
criteria provided, multiple submitters, no conflicts
37.
GRCh37:
Chr16:10989256
GRCh38:
Chr16:10895399
CIITAA57D, A33DMHC class II deficiency, Rheumatoid arthritisConflicting interpretations of pathogenicity
(May 4, 2022)
criteria provided, conflicting interpretations
38.
GRCh37:
Chr1:206945738
GRCh38:
Chr1:206772393
IL10, IL19, LOC128462409G15RInflammatory bowel disease, not provided, Susceptibility to HIV infection,
Graft-versus-host disease, susceptibility to, Rheumatoid arthritis
Conflicting interpretations of pathogenicity
(Oct 27, 2022)
criteria provided, conflicting interpretations
39.
GRCh37:
Chr16:11018177
GRCh38:
Chr16:10924320
CIITARheumatoid arthritis, MHC class II deficiency, MHC class II deficiency
Uncertain significance
(Aug 4, 2021)
criteria provided, multiple submitters, no conflicts
40.
GRCh37:
Chr16:11017837
GRCh38:
Chr16:10923980
CIITARheumatoid arthritis, MHC class II deficiency, MHC class II deficiency
Uncertain significance
(Oct 4, 2021)
criteria provided, multiple submitters, no conflicts
41.
GRCh37:
Chr16:11002000
GRCh38:
Chr16:10908143
CIITAR884H, R885H, R835H, R836H, R861HRheumatoid arthritis, MHC class II deficiency, MHC class II deficiency
Uncertain significance
(Aug 16, 2022)
criteria provided, multiple submitters, no conflicts
42.
GRCh37:
Chr16:11001445
GRCh38:
Chr16:10907588
CIITAP699L, P700L, P650L, P651L, P676LRheumatoid arthritis, MHC class II deficiency, MHC class II deficiency
Uncertain significance
(Mar 16, 2022)
criteria provided, multiple submitters, no conflicts
43.
GRCh37:
Chr16:10970902
GRCh38:
Chr16:10877045
CIITARheumatoid arthritisrisk factor
(Oct 1, 2006)
no assertion criteria provided
44.
GRCh37:
Chr1:114377568
GRCh38:
Chr1:113834946
AP4B1-AS1, PTPN22R620W, R596W, R565Wnot providedBenign
(Oct 17, 2018)
criteria provided, single submitter
45.
GRCh37:
Chr6:31515340
GRCh38:
Chr6:31547563
NFKBIL1Rheumatoid arthritisrisk factor
(Feb 1, 2003)
no assertion criteria provided
46.
GRCh37:
Chr5:131637309
GRCh38:
Chr5:132301616
SLC22A4Rheumatoid arthritisrisk factor
(Dec 1, 2003)
no assertion criteria provided
47.
GRCh37:
Chr1:160807715
GRCh38:
Chr1:160837925
CD244Rheumatoid arthritisrisk factor
(Oct 1, 2008)
no assertion criteria provided
48.
GRCh37:
Chr7:128578301
GRCh38:
Chr7:128938247
IRF5Rheumatoid arthritis, Systemic lupus erythematosus, susceptibility to, 10Pathogenic; risk factor
(Mar 15, 2008)
no assertion criteria provided
Format
Items per page
Sort by
Choose Destination